Title : Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.

Pub. Date : 2019 Nov

PMID : 31545468






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Through systematic pharmacological analysis, it was found that BBR serves a significant role in inhibiting HCC by affecting multiple pathways, especially the PI3K/AKT signaling pathway. Berberine AKT serine/threonine kinase 1 Homo sapiens
2 Furthermore, the docking approach indicated that the binding of BBR to AKT could lead to the suppression of AKT activity. Berberine AKT serine/threonine kinase 1 Homo sapiens
3 Furthermore, the docking approach indicated that the binding of BBR to AKT could lead to the suppression of AKT activity. Berberine AKT serine/threonine kinase 1 Homo sapiens
4 The present study examined the inhibitory effect of BBR on the PI3K/AKT pathway in HCC and identified that BBR downregulated the expressions of phosphorylated AKT and PI3K in MHCC97-H and HepG2 cells, inhibiting their growth, cell migration and invasion in a dose-dependent manner. Berberine AKT serine/threonine kinase 1 Homo sapiens
5 The present study examined the inhibitory effect of BBR on the PI3K/AKT pathway in HCC and identified that BBR downregulated the expressions of phosphorylated AKT and PI3K in MHCC97-H and HepG2 cells, inhibiting their growth, cell migration and invasion in a dose-dependent manner. Berberine AKT serine/threonine kinase 1 Homo sapiens
6 In addition, inhibition of the AKT pathway by BBR also contributed to cell apoptosis in MHCC97-H and HepG2 cells. Berberine AKT serine/threonine kinase 1 Homo sapiens
7 Taken together, the results of the present study suggested that BBR may be a promising antitumor drug for HCC that acts by inhibiting the PI3K/AKT pathway. Berberine AKT serine/threonine kinase 1 Homo sapiens